| [1] Beasley MB,Brambilla E,Travis WD. The 2004 World Health Organization classification of lung tumors [J].Semin Roentgenol,2005,40(2):90-97.[2] Travis WD,Travis LB,Devesa SS.Lung cancer [J].Cancer,1995,75(1Suppl1):191-202.[3] Worden FP,Kalemkerian GP.Therapeutic advances in small cell lung cancer [J].Expert Opin Investig Drugs,2000,9(3):565-579.[4] Socinski MA,Bogart JA.Limited-stage small-cell lung cancer:the current status of combined-modality therapy [J].J Clin Oncol,2007,25(26):4137-4145.[5] Seow A,Ng DP,Choo S,et al.Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women [J].Carcinogenesis,2006,27(6):1240-1244.[6] Johnson SK,Kerr KM,Chapman AD,et al.Immune cell infiltrates and prognosis in primary carcinoma of the lung [J].Lung Cancer,2000,27(1):27-35.[7] Hiraoka K,Miyamoto M,Cho Y,et al.Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma [J].Br J Cancer,2006,94(2):275-280.[8] Munn DH,Bronte V.Immune suppressive mechanisms in the tumor microenvironment [J].Curr Opin Immunol,2016,39:1-6.[9] Zhu J,Yamane H,Paul WE.Differentiation of effector CD4 T cell populations [J].Ann Rev Immunol,2010,28:445-489.[10] Cox CA,Shi G,Yin H,et al.Both Th1 and Th17 are immunopathogenic but differ in other key biological activities [J].J Immunol,2008,180(11):7414-7422.[11] Davidson MG,Alonso MN,Yuan R,et al.Th17 cells induce Th1 polarizing monocyte-derived dendritic cells [J].J Immunol,2013,191(3):1175-1187.[12] Ye ZJ,Zhou Q,Yin W,et al.Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion [J].Am J Respir Crit Care Med,2012,186(11):1168-1179.[13] Nakatsukasa H,Zhang D,Maruyama T,et al.The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells [J].Nat Immunol,2015,16(10):1077-1084.[14] Froidure A,Shen C,Gras D,et al.Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses [J].Allergy,2014,69(8):1068-1076.[15] Chen N,Lu K,Li P,et al.Overexpression of IL-9 induced by STAT6 activation promotes the pathogenesis of chronic lymphocytic leukemia [J].Int J Clin Exp Pathol,2014,7(5):2319-2323.[16] Niedbala W,Besnard AG,Nascimento DC,et al.Nitric oxide enhances Th9 cell differentiation and airway inflammation [J].Nat Commun,2014,5:4575.[17] Ma CS,Tangye SG,Deenick EK.Human Th9 cells:inflammatory cytokines modulate IL-9 production through the induction of IL-21 [J].Immunol Cell Biol,2010,88(6):621-623.[18] Li H,Rostami A.IL-9:basic biology,signaling pathways in CD4+ T cells and implications for autoimmunity [J].J Neuroimmune Pharmacol,2010,5(2):198-209.[19] Adamson AS,Collins K,Laurence A,et al.The current status of lymphocyte signaling:new roles for old players [J].Curr Opin Immunol,2009,21(2):161-166. |
